SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001625101-20-000041
Filing Date
2020-08-10
Accepted
2020-08-10 16:42:00
Documents
58
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q plse-20200630x10q.htm   iXBRL 10-Q 2780313
2 EX-10.1 plse-20200630xex10_1.htm EX-10.1 41762
3 EX-31.1 plse-20200630xex31_1.htm EX-31.1 23385
4 EX-31.2 plse-20200630xex31_2.htm EX-31.2 23561
5 EX-32.1 plse-20200630xex32_1.htm EX-32.1 21148
  Complete submission text file 0001625101-20-000041.txt   7874339

Data Files

Seq Description Document Type Size
6 EX-101.SCH plse-20200630.xsd EX-101.SCH 34394
7 EX-101.CAL plse-20200630_cal.xml EX-101.CAL 47954
8 EX-101.DEF plse-20200630_def.xml EX-101.DEF 126666
9 EX-101.LAB plse-20200630_lab.xml EX-101.LAB 305861
10 EX-101.PRE plse-20200630_pre.xml EX-101.PRE 274426
11 EXTRACTED XBRL INSTANCE DOCUMENT plse-20200630x10q_htm.xml XML 1429156
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

IRS No.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37744 | Film No.: 201089953
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences